Effect of Hominis Placenta Pharmacopuncture for a Patient with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: Mild cognitive impairment (MCI) is condition of cognitive decline shown in transition from normal aging to dementia. Hominis placenta pharmacopuncture (HPP) is a treatment that combines effects of medication and acupuncture by injecting Hominis placenta into acupoints. The objective of this study was to evaluate the efficacy and safety of HPP for MCI. Methods: This was a randomized, double-blind, placebo-controlled, two-center clinical trial. Eligible patients were randomly allocated to either the HPP group or the placebo group. HPP or saline as placebo was administered to participants for eight weeks. Changes in symptoms were observed. The primary outcome was difference in mean change of Korean Version of the Montreal Cognitive Assessment (MoCA-K) score between the HPP group and the placebo group. Cognitive function, overall status of mood and sleep, and quality of life (QoL) were also assessed. Safety assessment and economic analysis were then conducted. Results: Thirty participants were enrolled. One participant in the placebo group dropped out. The score of MoCA-K increased after treatment. Its mean change was smaller in the HPP group than in the control group. HPP ameliorated Global Deterioration Scale and Korean Dementia Rating Scale subtests for attention, organization, and memory compared to the placebo. However, none of them was significantly different between the two groups. Mood, sleep, and QoL all improved more in the HPP group than in the placebo group, although differences between the two groups were not statistically significant. There was no adverse event probably related to the drug. HPP treatment needed KRW 345,000 more than the placebo group in improving Geriatric Quality of Life scale-Dementia score by one point for one year. Conclusions: Although HPP treatment did not significantly improve cognition, it changed behavioral and psychological symptoms in MCI.
Abstract
Objectives: Mild cognitive impairment (MCI) is condition of cognitive decline shown in transition from normal aging to dementia. Hominis placenta pharmacopuncture (HPP) is a treatment that combines effects of medication and acupuncture by injecting Hominis placenta into acupoints. The objective of this study was to evaluate the efficacy and safety of HPP for MCI. Methods: This was a randomized, double-blind, placebo-controlled, two-center clinical trial. Eligible patients were randomly allocated to either the HPP group or the placebo group. HPP or saline as placebo was administered to participants for eight weeks. Changes in symptoms were observed. The primary outcome was difference in mean change of Korean Version of the Montreal Cognitive Assessment (MoCA-K) score between the HPP group and the placebo group. Cognitive function, overall status of mood and sleep, and quality of life (QoL) were also assessed. Safety assessment and economic analysis were then conducted. Results: Thirty participants were enrolled. One participant in the placebo group dropped out. The score of MoCA-K increased after treatment. Its mean change was smaller in the HPP group than in the control group. HPP ameliorated Global Deterioration Scale and Korean Dementia Rating Scale subtests for attention, organization, and memory compared to the placebo. However, none of them was significantly different between the two groups. Mood, sleep, and QoL all improved more in the HPP group than in the placebo group, although differences between the two groups were not statistically significant. There was no adverse event probably related to the drug. HPP treatment needed KRW 345,000 more than the placebo group in improving Geriatric Quality of Life scale-Dementia score by one point for one year. Conclusions: Although HPP treatment did not significantly improve cognition, it changed behavioral and psychological symptoms in MCI.
참고문헌 (37)
- Ministry of Health and Welfare, "The 2nd National dementia management general strategies (2013-2015)", ~ (2012)
- Gräsel E, "Non-drug therapies for dementia : an overview of the current situation with regard to proof of effectiveness", Dement Geriatr Cogn Disord, 15(3), pp.115~125 (2003)
- Korean Pharmacopuncture Institute Science Committee, "Pharmacopuncturology" (2011), Elsevier Korea
- Shin MK, "Clinical traditional herbalogy. Vol. 172" (1997), Younglimsa
- 이정훈, "말초성 안면신경마비에 대한 황련해독탕약침과 자하거약침의 효능 : 후향적 비교 연구", Korean Journal of Acupuncture, 32(4), pp.199~207 (2015), 경락경혈학회[DOI]
- 정기훈, "특발성 동안신경마비의 자하거 약침 치료 3례", Journal of Pharmacopuncture, 12(1), pp.91~98 (2009), 대한약침학회
- 노주환, "중풍 환자의 하지 경직에 대한 자하거 약침의 효과 연구", Journal of Pharmacopuncture, 12(4), pp.97~110 (2009), 대한약침학회
- 최석우, "봉약침과 자하거약침 시술로 호전된 횡단성척수염 환자에 대한 임상적 고찰", Journal of Pharmacopuncture, 8(2), pp.17~22 (2005), 대한약침학회
- 이병훈, "紫河車 藥鍼이 βA로 誘導된 Alzheimer's Disease 病態 모델에 미치는 影響", 동의신경정신과학회지, 19(2), pp.41~64 (2008), 대한한방신경정신과학회
- "The Effects of Hominis Placenta Pharmacopuncture (PLC) on Cognitive Dysfunction & Behavioral and Psychological Symptoms (BPSD) in the Animal Model of Alzheimer’s Disease" (2020)[URL]
- Kogure C, "Human placenta extract ameliorates memory dysfunction and dendritic atrophy in a 5XFAD mouse model of A lzheimer’s disease", Tradit Kampo Med, 4(2), pp.94~104 (2017)
- 김윤나, "Treatment of Hominis placenta pharmacopuncture for a patient with mild neurocognitive disorder: Case report", Journal of Pharmacopuncture, 22(4), pp.279~283 (2019), 대한약침학회[DOI]
- Kim Y, "Efficacy and safety of Hominis placenta pharmacopuncture on mild cognitive impairment : Randomized, double blind, placebo-controlled, multi-center trial", Medicine(Baltimore), 99(46), pp.e22956~ (2020)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders(DSM-5®)" (2013), American Psychiatric Pub
- Xie L, "30 cases of mild cognitive impairment treated by Buyang Huanwu Decoction and donepezil", Jiangxi J Tradit Chin Med, 46(04), pp.26~28 (2015)
- 이효진, "임상 연구에서 연구 표본수의 산출", 대한 견주관절 학회지, 16(1), pp.53~57 (2013), 대한견주관절학회
- Nasreddine ZS, "The Montreal Cognitive Assessment, MoCA : a brief screening tool for mild cognitive impairment", J Am Geriatr Soc, 53(4), pp.695~699 (2005)
- Lee J-Y, "Brief screening for mild cognitive impairment in elderly outpatient clinic : validation of the Korean version of the Montreal Cognitive Assessment", J Geriatr Psychiatry Neurol, 21(2), pp.104~110 (2008)
- Chey JY, "The Validity and Reliability of the Korean Dementia Rating Scale", Korean J Clin Psychol, 17(1), pp.247~258 (1998)
- Mattis S., "Dementia rating scale: DRS: Professional manual", PAR, ~ (1998)
- 한지원, "치매 선별용 간이정신상태검사(Mini-Mental State Examination for Dementia Screening；MMSE-DS)와 단축형 MMSE-DS(SMMSE-DS)의 한국 노인 정상규준 연구", 노인정신의학, 14(1), pp.27~37 (2010), 대한노인정신의학회
- Reisberg B, "The Global Deterioration Scale for assessment of primary degenerative dementia", Am J Psychiatry, 139(9), pp.1136~1139 (1982)[DOI]
- Hughes CP, "A new clinical scale for the staging of dementia", Br J Psychiatry, 140(6), pp.566~572 (1982)
- Choi SH, "Estimating the validity of the Korean version of expanded clinical dementia rating(CDR)scale", J Korean Neurol Assoc, 19(6), pp.585~ (2001)
- Beck A, "Manual for the Beck depression inventory-II (BDI-II)", Psychological Corporation, ~ (1996)
- Spielberger CD, "Manual for the State-Trait Anxiety Inventory" (1983), Consulting Psychologists Press
- Spielberger, C. D., "Manual for the State-Trait Anger Expression Inventory–2" (1999), Psychological Assessment Resources
- Morin CM, "Insomnia : psychological assessment and management" (1993), Guilford Press
- Kind P., "Quality of life and pharmacoeconomics in clinical trials. B. B", pp.191~201 (1996), Lippincott-Raven Publishers
- Lee HS, "The Standardization of the Geriatric Quality of Life scale-Dementia(GQOL-D)", J Korean Geriatr Soc, 8(3), pp.151~164 (2004)
- A survey of the elderly with dementia 2011, "Chung K hee", Ministry of Health and Welfare, Korea Institute for Health and Affairs, ~, pp.Report No.: 11-1352000-000672-12 (2011)
- Korean Dementia Observatory 2019, "Lee J", National Institute of Dementia, ~, pp.Report No.: NIDR-1902-0028 (2020)
- Korean Dementia Observatory 2020, "Lee J", National Institute of Dementia, ~, pp.Report No.: NIDR-2002-0031 (2021)
- Livingston G, "Dementia prevention, intervention, and care : 2020 report of the Lancet Commission", The Lancet, 396(10248), pp.413~446 (2020)
- Kong M, "Effect of human placental extract on health status in elderly Koreans", Evid Based Complement Alternat Med, 2012, pp.732915~ (2012)
- Kim J, "Effect of Human Placental Extract on Quality of Life in Postmenopausal Woman", HealthMED, 11(4), pp.192~ (2017)
- Han C-W, "Development of the Korean version of Short-Form 36-Item Health Survey : health related QOL of healthy elderly people and elderly patients in Korea", Tohoku J Exp Med, 203(3), pp.189~194 (2004)